Proton pump inhibitors and risk of gastric cancer: a population-based cohort study.
about
Overutilization of proton-pump inhibitors: what the clinician needs to knowAcid suppressive drugs and gastric cancer: a meta-analysis of observational studiesEvidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.Should peri-gastrectomy gastric acidity be our focus among gastric cancer patients?Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implicationsProton pump inhibitors: Risks of long-term use.Divergent trends for gastric cancer incidence by anatomical subsite in US adults.Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case-control studyEpidemiological aspects of gastric adenocarcinoma: are predictive diagnostics and targeted preventive measures possible?Long-term risk of gastrointestinal cancers in persons with gastric or duodenal ulcers.The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.Prescribing proton pump inhibitors: is it time to pause and rethink?LINX(™) Reflux Management System: magnetic sphincter augmentation in the treatment of gastroesophageal reflux disease.Obesity and related risk factors in gastric cardia adenocarcinoma.Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms.Inhibition of lysosomal enzyme activities by proton pump inhibitors.Acid-suppressing therapies and subsite-specific risk of stomach cancer.What you need to know when you prescribe a proton pump inhibitor.Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors.Proton-pump inhibitors: understanding the complications and risks.Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study.Proton pump inhibitors on pancreatic cancer risk and survival.Gastrin receptor pharmacology.Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use.Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study.Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden.
P2860
Q24634086-133294EC-A57F-4CAF-9A4B-5F8590F293D3Q27025101-0845CF5C-E93D-443D-91A5-207D8CA6FAF2Q30249468-9F9ADF8C-A111-4B68-AF7A-F6563FD8DEB8Q33735357-6453A9FB-BBD1-47DF-A940-E5952ADBD0A3Q33949498-84B6476C-A57E-479E-9470-E31D79DB459DQ34549406-D36EE521-1466-4402-A6D8-F07AF8E96B2DQ35449763-7886F4F2-B344-44EF-93FD-44EB3A0994F2Q35653793-70E86E57-5DB3-4347-82D2-D5733AD9B33EQ36117678-B9E00F2C-1394-479D-BEC8-F488D1155CCAQ37045624-F7748891-FCF8-4168-860A-AEE27F6CA839Q37709906-819CA033-D46E-4972-919B-668AD9F85187Q37987204-514162AC-5C67-40FF-9894-431665699624Q38067129-DE0AC247-BBFD-473A-9C3C-4C17603B4BF7Q38248208-063C531E-6DCB-46EF-A1A9-CDD2079D48E8Q38547653-35F97022-8E36-43C6-9B3A-D0EA4A62105CQ38631128-D7117D3D-A5AC-4B55-9B44-B18A9A532740Q39182584-25C856EF-2CD4-4CAF-87E7-BEFFA9AB6379Q40270202-E75E1221-C9D8-4937-8E76-B257D48B331CQ41060355-B6136B8E-B89D-40FC-838C-8239BBF26E2DQ41146448-9E158B1D-8BB2-43EB-BF3A-74F63B1F262AQ41996131-1A4AEB43-3F6F-4C08-98F2-8C15406C0D60Q47095023-5C9D9ADF-D7D7-41BA-85C5-AD9054CB4DF0Q49355765-5CB27829-155F-4F24-BE4F-9BC28FDA9CEEQ50970848-46FAFD25-B435-4C1E-9419-8CA20BCF15ECQ54483223-DCBB89FC-579B-414B-BFCE-7E0F74480C24Q55493690-F7CAAE35-EE11-4108-B6A7-0E414B0DE87AQ55709336-87464EEE-93B0-44B2-8E47-78A229C3D662Q55716567-4418C2D3-057A-4B14-9F44-702BDB6A50A9
P2860
Proton pump inhibitors and risk of gastric cancer: a population-based cohort study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proton pump inhibitors and risk of gastric cancer: a population-based cohort study.
@en
Proton pump inhibitors and risk of gastric cancer: a population-based cohort study.
@nl
type
label
Proton pump inhibitors and risk of gastric cancer: a population-based cohort study.
@en
Proton pump inhibitors and risk of gastric cancer: a population-based cohort study.
@nl
prefLabel
Proton pump inhibitors and risk of gastric cancer: a population-based cohort study.
@en
Proton pump inhibitors and risk of gastric cancer: a population-based cohort study.
@nl
P2093
P2860
P356
P1476
Proton pump inhibitors and risk of gastric cancer: a population-based cohort study.
@en
P2093
H T Sørensen
R W Thomsen
S Christensen
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605024
P407
P577
2009-04-07T00:00:00Z
P5875
P6179
1013314939